(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(-0.09%) $0.926
(-0.16%) $10.82
(-0.13%) $0.791
(-0.09%) $92.49
Live Chart Being Loaded With Signals
SkinBioTherapeutics plc, a life science company, engages in the research and development of technology that harnesses the human microbiome to improve health...
Stats | |
---|---|
Today's Volume | 2.88M |
Average Volume | 671 094 |
Market Cap | 24.58M |
EPS | £0 ( 2024-03-25 ) |
Last Dividend | £0 ( N/A ) |
Next Dividend | £0 ( N/A ) |
P/E | -6.37 |
ATR14 | £0.209 (1.67%) |
Volume Correlation
SkinBioTherapeutics PLC Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
SkinBioTherapeutics PLC Correlation - Currency/Commodity
SkinBioTherapeutics PLC Financials
Annual | 2022 |
Revenue: | £132 057 |
Gross Profit: | £41 653.00 (31.54 %) |
EPS: | £-0.0172 |
Q2 | 2023 |
Revenue: | £106 576 |
Gross Profit: | £23 107.00 (21.68 %) |
EPS: | £-0.00750 |
Q4 | 2022 |
Revenue: | £55 072.00 |
Gross Profit: | £5 609.00 (10.18 %) |
EPS: | £-0.00900 |
Q2 | 2022 |
Revenue: | £76 985.00 |
Gross Profit: | £35 388.00 (45.97 %) |
EPS: | £-0.00820 |
Financial Reports:
No articles found.
SkinBioTherapeutics PLC
SkinBioTherapeutics plc, a life science company, engages in the research and development of technology that harnesses the human microbiome to improve health. The company develops SkinBiotix technology that can enhance the barrier effect of skin models, protect skin from infections, and repair wounds; and AxisBiotix that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company has a collaboration agreement with Croda Plc; the University of Manchester to develop immune-supporting microbiome formulations; and Winclove Probiotics B.V. for the development of a probiotic blend of good bacterial strains based on the modifying properties of specific bacterial species in known psoriasis pathways. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators